These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 18209601)

  • 21. Association of serum gamma-glutamyltransferase and alanine aminotransferase activities with risk of type 2 diabetes mellitus independent of fatty liver.
    Kim CH; Park JY; Lee KU; Kim JH; Kim HK
    Diabetes Metab Res Rev; 2009 Jan; 25(1):64-9. PubMed ID: 19065605
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [On the accuracy of laboratory tests in the diagnosis of fatty liver].
    Kaffarnik H; Gross W; Juchems R
    Munch Med Wochenschr; 1967 Jan; 109(4):199-200. PubMed ID: 6071799
    [No Abstract]   [Full Text] [Related]  

  • 23. What is the best indicator for evaluating treatment response in nonalcoholic fatty liver disease: histology or aminotransferase levels?
    Akyuz F; Demir K; Cevikbas U; Okten A
    J Gastroenterol Hepatol; 2005 Jan; 20(1):167-8. PubMed ID: 15610470
    [No Abstract]   [Full Text] [Related]  

  • 24. Fatty liver in adolescents on the U.S.-Mexico border.
    Sharp DB; Santos LA; Cruz ML
    J Am Acad Nurse Pract; 2009 Apr; 21(4):225-30. PubMed ID: 19366381
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Contribution to the study of prediabetic states].
    Streda M
    Vnitr Lek; 1968 Jan; 14(1):18-20. PubMed ID: 5673838
    [No Abstract]   [Full Text] [Related]  

  • 26. [Treatment of fatty liver with essential phospholipids].
    Arendt R; Nowotny P; Teichmann W
    Z Gesamte Inn Med; 1970 Jul; 25(13):587-9. PubMed ID: 5523267
    [No Abstract]   [Full Text] [Related]  

  • 27. [Therapeutic experience in diabetes mellitus association with liver disorders].
    Toyoda M
    Nihon Rinsho; 1969 Aug; 27(8):2119-22. PubMed ID: 5390418
    [No Abstract]   [Full Text] [Related]  

  • 28. [How I investigate the new criteria for the diagnosis of diabetes mellitus].
    Scheen AJ; Paquot N; Lefèbvre PJ
    Rev Med Liege; 1997 Sep; 52(9):606-9. PubMed ID: 9441346
    [No Abstract]   [Full Text] [Related]  

  • 29. [Use of a method for assessing the glucose tolerance test by a generalized criterion in detecting the early stages of diabetes mellitus in the universal dispensary care of the population].
    Efimov AS; Antomonov IuG; Chernobrov AD; Parokonnaia NK
    Ter Arkh; 1987; 59(5):135-8. PubMed ID: 3616934
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Catarrhal hepatosis or acute fatty liver?].
    Meyer zu Schwabedissen O
    Med Klin; 1967 Sep; 62(37):1419-21. PubMed ID: 5593031
    [No Abstract]   [Full Text] [Related]  

  • 31. [Proceedings: Use of the enzymatic determination of glycemia with the Dextrostix-Reflectance Meter in mass screening for diabetes mellitus].
    Marigo S; Del Nevo G; Bini PP
    Quad Sclavo Diagn; 1973 Mar; 9(1):95-102. PubMed ID: 4788735
    [No Abstract]   [Full Text] [Related]  

  • 32. Association of raised liver transaminases with physical inactivity, increased waist-hip ratio, and other metabolic morbidities in severely obese children.
    Lee YS; Kek BL; Poh LK; Saw SM; Loke KY
    J Pediatr Gastroenterol Nutr; 2008 Aug; 47(2):172-8. PubMed ID: 18664869
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Detection of diabetes].
    Dérot M; Rathery M
    Bull Acad Natl Med; 1970; 154(3):77-84. PubMed ID: 4910969
    [No Abstract]   [Full Text] [Related]  

  • 34. [Plasma tyrosine level in liver diseases].
    Selmair H; Langness U; Zimmermann J; Herborn U
    Med Klin; 1971 Jun; 66(30):1049-52. PubMed ID: 5569262
    [No Abstract]   [Full Text] [Related]  

  • 35. Back to the future--do IGT and IFG have value as clinical entities?
    Colagiuri S; Borch-Johnsen K; Wareham NJ
    Diabetes Res Clin Pract; 2008 Aug; 81(2):131-3. PubMed ID: 18657716
    [No Abstract]   [Full Text] [Related]  

  • 36. Nonalcoholic fatty liver disease in HIV-infected patients referred to a metabolic clinic: prevalence, characteristics, and predictors.
    Guaraldi G; Squillace N; Stentarelli C; Orlando G; D'Amico R; Ligabue G; Fiocchi F; Zona S; Loria P; Esposito R; Palella F
    Clin Infect Dis; 2008 Jul; 47(2):250-7. PubMed ID: 18532884
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Diagnosis of hepatosis].
    Nöcker J; Hartleb O; Weidemann H
    Dtsch Z Verdau Stoffwechselkr; 1966 Feb; 25(6):349-54. PubMed ID: 5998358
    [No Abstract]   [Full Text] [Related]  

  • 38. [2 out of 3 cardiac patients are undetected diabetics. Screening with the oral glucose tolerance test!].
    Einecke D
    MMW Fortschr Med; 2004 Sep; 146(39):20. PubMed ID: 15532409
    [No Abstract]   [Full Text] [Related]  

  • 39. Metformin use in children with nonalcoholic fatty liver disease: an open-label, 24-month, observational pilot study.
    Nobili V; Manco M; Ciampalini P; Alisi A; Devito R; Bugianesi E; Marcellini M; Marchesini G
    Clin Ther; 2008 Jun; 30(6):1168-76. PubMed ID: 18640473
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Liver enzymes and risk of diabetes and cardiovascular disease: results of the Firenze Bagno a Ripoli (FIBAR) study.
    Monami M; Bardini G; Lamanna C; Pala L; Cresci B; Francesconi P; Buiatti E; Rotella CM; Mannucci E
    Metabolism; 2008 Mar; 57(3):387-92. PubMed ID: 18249212
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.